Skip to main content
×
×
Home

Commentary: Response to Professor Kerwin

  • T. R. E. Barnes (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Commentary
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Commentary
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Commentary
      Available formats
      ×
Abstract
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Aitchison, K. J. & Kerwin, R. W. (1995) The cost and benefit of clozapine therapy in the UK (Abstract). Schizophrenia Research, 15, 141.
Baldessarini, R. J., Cohen, B. M. & Teicher, M. H. (1988) Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry, 46, 7991.
Barnes, T. R. E. & Curson, D. A. (1994) Long-acting depot antipsychotics: a risk-benefit assessment. Drug Safety, 10, 464479.
Barnes, T. R. E. & Curson, D. A. & Edwards, J. G. (1993) The side-effects of antipsychotic drugs. I. Neuropsychiatric effects. In Antipsychotic Drugs and Their Side-Effects (ed. T. R. E. Barnes), pp. 213247. London: Academic Press.
Barnes, T. R. E. & Curson, D. A. Milavic, G., Curson, D. A., et al (1983) Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine. Social Psychiatry, 18, 193199.
Bebbington, P. E. (1995) The content and context of compliance. International Clinical Psychopharmacology, 9 (Suppl. 5), 4150.
Bosanquet, N. & Zajdler, A. (1993) Psychopharmacology and the ethics of resource allocation. British Journal of Psychiatry, 162, 2932.
Bredbacka, P. E., Paukkala, E., Kinnunen, E., et al (1993) Can severe cardiorespiratory dysregulation induced by clozapine monotherapy be predicted? International Clinical Psychopharmacology, 8, 205206.
Carpenter, W. T., Conley, R. R., Buchanan, R. W., et al (1995) Patient response and resource management: another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827832.
Davies, L. M. & Drummond, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. British Journal of Psychiatry, 162, 3842.
Edwards, J. G. & Barnes, T. R. E. (1993) The side-effects of antipsychotic drugs. II. Effects on other physiological systems. In Antipsychotic Drugs and Their Side-Effects. (ed. T. R. E. Barnes), pp. 249275. London: Academic Press.
Fitton, A. & Benfield, P. (1993) Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. PharmacoEconomics, 4, 131156.
Grohmann, R., Ruther, E., Sassim, N., et al (1989) Adverse effects of clozapine. Psychopharmacology, 99, S101S104.
Healy, D. (1993) Psychopharmacology and the ethics of resource allocation. British Journal of Psychiatry, 162, 2329.
Hirsch, S. R. & Barnes, T. R. E. (1994) Clinical use of high-dose neuroleptics. British Journal of Psychiatry, 164, 9496.
Hirsch, S. R. & Barnes, T. R. E. & Puri, B. K. (1993) Clozapine: progress in treating refractory schizophrenia (Editorial). British Medical Journal 306, 14271428.
Jusic, N. & Lader, M. (1994) Post-mortem antipsychotic drug concentrations and unexplained deaths. British Journal of Psychiatry, 165, 787791.
Kane, J. M. (1994) Risperidone (Editorial). American Journal of Psychiatry, 151, 802803.
Keck, P. E., Cohen, B. M., Baldessarini, R. J., et al (1989) Time course of antipsychotic effects of neuroleptic drugs. American Journal of Psychiatry, 146, 12891292.
Kinon, B. J., Kane, J. M., Johns, C., et al (1993) Treatment of neuroleptic-resistant schizophrenic relapse. Psychopharmacology Bulletin, 29, 309314.
Lamberti, J. S., Bellnier, T. & Schwarzkopf, S. B. (1992) Weight gain among schizophrenic patients treated with clozapine. American Journal of Psychiatry, 149, 689690.
Matheson, L. A., Cook, H. M., McKenna, P., et al (1994) Value for money care for patients with schizophrenia, British Journal of Medical Economics, 7, 2534.
May, P. R. A., Dencker, S. J., Hubbard, J. W., et al (1988) A systematic approach to treatment resistance in schizophrenic disorders. In Treatment Resistance in Schizophrenia (eds S. J. Dencker & F. Kulhanek), pp. 2233. Viewig: Braunschweig.
Meltzer, H. Y. (1995) Clozapine: is another view valid? (Editorial). American Journal of Psychiatry, 152, 821823.
Pacia, S. V. & Devinsky, O. (1994) Clozapine-related seizures: experience with 5629 patients. Neurology, 44, 22472249.
Reardon, G. T., Rifkin, A., Schwartz, A., et al (1989) Changing patterns of neuroleptic dosage over a decade. American Journal of Psychiatry, 146, 726729.
Revicki, D. A., Luce, B. R., Weschler, J. M., et al (1990) Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. Hospital and Community Psychiatry, 41, 850854.
Sassim, N. & Grohmann, R. (1988) Adverse drug reactions with clozapine and simultaneous application of benzodiazepines. Pharmacopsychiatry, 21, 306307.
Shalev, A., Hermesh, H., Rothberg, J., et al (1993) Poor neuroleptic response in acutely exacerbated schizophrenic patients. Acta Psychiatrica Scandinavica, 87, 8691.
Toth, P. & Frankenburg, F. R. (1994) Clozapine and seizures: a review. Canadian Journal of Psychiatry, 39, 236238.
Viner, M. W., Escobar, J. I. & Werick, T. (1994) Clozapine plus psychoeducation in treatment refractory schizophrenia (Abstract). Neuropsychopharmacology, 10, S207.
Warner, J. P., Harvey, C. A. & Barnes, T. R. E. (1994) Clozapine and urinary incontinence. International Clinical Psychopharmacology, 9, 207209.
Welch, J., Manschrek, T. & Redmond, D. (1994) Clozapine-induced seizures and EEG changes. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 250256.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 2 *
Loading metrics...

Abstract views

Total abstract views: 4 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 20th July 2018. This data will be updated every 24 hours.

Commentary: Response to Professor Kerwin

  • T. R. E. Barnes (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *